LIF Antikörper (AA 23-202)
-
- Target Alle LIF Antikörper anzeigen
- LIF (Leukemia Inhibitory Factor (LIF))
-
Bindungsspezifität
- AA 23-202
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LIF Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Kreuzreaktivität (Details)
- No cross reactivity with other proteins.
- Aufreinigung
- Immunogen affinity purified
- Immunogen
-
E.coli-derived human LIF recombinant protein (Position: S23-F202). Human LIF shares 78% and 82% amino acid (aa) sequences identity with mouse and rat LIF, respectively.
Type of Immunogen: Recombinant protein - Isotyp
- IgG
- Top Product
- Discover our top product LIF Primärantikörper
-
anti-Leukemia Inhibitory Factor (LIF) (AA 2-201) antibody
LIF Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Leukemia Inhibitory Factor (LIF) (AA 2-201) antibodyLIF Reaktivität: Human WB, IHC, IP, ICC Wirt: Maus Monoclonal C1 unconjugated
anti-Leukemia Inhibitory Factor (LIF) (AA 72-101) antibodyLIF Reaktivität: Human WB, IHC, ELISA, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Leukemia Inhibitory Factor (LIF) (AA 72-101) antibodyLIF Reaktivität: Human, Ratte WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB21725 unconjugated
anti-Leukemia Inhibitory Factor (LIF) (AA 101-202) antibodyLIF Reaktivität: Human, Maus WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Leukemia Inhibitory Factor (LIF) (AA 23-202) antibodyLIF Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Leukemia Inhibitory Factor (LIF) antibodyLIF Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Leukemia Inhibitory Factor (LIF) (C-Term) antibodyLIF Reaktivität: Human WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Leukemia Inhibitory Factor (LIF) (AA 23-202) antibodyLIF Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Leukemia Inhibitory Factor (LIF) (C-Term) antibodyLIF Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Rekonstitution
- Distilled water
- Konzentration
- Lot specific
- Buffer
- Contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2 HPO4, 0.05 mg sodium azide per 100 μg antibody.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- At -20°C for 1 year. After reconstitution, at 4°C for 1 month. It can also be aliquotted and stored frozen at -20°C for a longer time.Avoid freeze-thaw cycles.
-
- Target
- LIF (Leukemia Inhibitory Factor (LIF))
- Andere Bezeichnung
- LIF (LIF Produkte)
- Synonyme
- CDF antikoerper, DIA antikoerper, HILDA antikoerper, MLPLI antikoerper, LIF, interleukin 6 family cytokine antikoerper, leukemia inhibitory factor antikoerper, LIF antikoerper, Lif antikoerper
- Hintergrund
-
Name/Gene ID: LIF
Synonyms: LIF, DIA, Emfilermin, HILDA, Melanoma-derived LPL inhibitor, MLPLI, Leukemia inhibitory factor, CDF, D factor, Human interleukin in DA cells - Gen-ID
- 3976
- Pathways
- JAK-STAT Signalweg, Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, Stem Cell Maintenance, Growth Factor Binding
-
